Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

602 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design details for overdose education and take-home naloxone kits: Codesign with family medicine, emergency department, addictions medicine and community.
Sellen K, Goso N, Halleran L, Mulvale-Fletcher A, Sarmiento F, Ligabue F, Handford C, Klaiman M, Milos G, Wright A, Charles M, Sniderman R, Hunt R, Parsons JA, Leece P, Hopkins S, Shahin R, Jüni P, Morrison L, Campbell DM, Strike C, Orkin A; SOONER Investigators. Sellen K, et al. Among authors: juni p. Health Expect. 2022 Oct;25(5):2440-2452. doi: 10.1111/hex.13559. Epub 2022 Jul 31. Health Expect. 2022. PMID: 35909312 Free PMC article.
Mixed methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) trial.
Orkin AM, Charles M, Norris K, Thomas R, Chapman L, Wright A, Campbell DM, Handford C, Klaiman M, Hopkins S, Shahin R, Thorpe K, Jüni P, Parsons J, Sellen K, Goso N, Hunt R, Leece P, Morrison LJ, Stergiopoulos V, Turner S, Strike C. Orkin AM, et al. Among authors: juni p. Resusc Plus. 2021 May 14;6:100131. doi: 10.1016/j.resplu.2021.100131. eCollection 2021 Jun. Resusc Plus. 2021. PMID: 34223388 Free PMC article.
Corrigendum to "Mixed methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) trial" [Resuscitation Plus 6 (2021) 100131].
Orkin AM, Charles M, Norris K, Thomas R, Chapman L, Wright A, Campbell DM, Handford C, Klaiman M, Hopkins S, Shahin R, Thorpe K, Juni P, Parsons J, Sellen K, Goso N, Hunt R, Leece P, Morrison LJ, Stergiopoulos V, Turner S, Strike C. Orkin AM, et al. Among authors: juni p. Resusc Plus. 2021 Sep 10;7:100158. doi: 10.1016/j.resplu.2021.100158. eCollection 2021 Sep. Resusc Plus. 2021. PMID: 34553182 Free PMC article.
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
Wright JK, Tan DHS, Walmsley SL, Hulme J, O'Connor E, Snider C, Cheng I, Chan AK, Borgundvaag B, McLeod S, Gollob MH, Clarke RJ, Dresser L, Haji F, Mazzulli T, Mubareka S, Jüni P, Lee D, Tomlinson G, Kain KC, Landes M. Wright JK, et al. Among authors: juni p. Trials. 2020 Jul 14;21(1):647. doi: 10.1186/s13063-020-04577-8. Trials. 2020. PMID: 32665039 Free PMC article.
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.
Orkin AM, Gill PJ, Ghersi D, Campbell L, Sugarman J, Emsley R, Steg PG, Weijer C, Simes J, Rombey T, Williams HC, Wittes J, Moher D, Richards DP, Kasamon Y, Getz K, Hopewell S, Dickersin K, Wu T, Ayala AP, Schulz KF, Calleja S, Boutron I, Ross JS, Golub RM, Khan KM, Mulrow C, Siegfried N, Heber J, Lee N, Kearney PR, Wanyenze RK, Hróbjartsson A, Williams R, Bhandari N, Jüni P, Chan AW; CONSERVE Group. Orkin AM, et al. Among authors: juni p. JAMA. 2021 Jul 20;326(3):257-265. doi: 10.1001/jama.2021.9941. JAMA. 2021. PMID: 34152382
602 results